ARDAN PHARMA is semifinalist in AIM-HI Accelerator Competition

Our CEO is participating in 2021 Women’s Venture Competition launched by AIM-HI Accelerator. The AIM-HI Accelerator Fund is an independent 501(C)(3) non-profit organization, established with an initial grant from the National Foundation for Cancer Research with the vision to accelerate the translation of cancer drug discoveries by investing in seed-stage companies. It is a new paradigm through venture philanthropy to fund start-up oncology companies that commercialize innovative laboratory breakthroughs which can potentially save cancer patients’ lives.

Learn more: https://lnkd.in/gGQrpBD